Does Sanofi pay well?
Not competitive in compensating employees Compared to the industry and other public companies, Sanofi is well below average in pay raises. Long-term employees are paid much less than the market.
Is Sanofi a good company to work for?
Glassdoor rating: 3.6 According to Glassdoor ratings, Sanofi scored highest in the categories of compensation and benefits and work/life balance, and 70% of employees would recommend the company as a place to work to a friend.
What drugs does Sanofi make?
Medications Available
- Adacel® Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Absorbed.
- Adlyxin® (lixisenatide injection)
- Admelog® (insulin lispro injection) 100 Units/mL.
- Apidra® (insulin glulisine injection) 100 Units/mL.
- Imogam® Rabies-HT Rabies Immune Globulin (Human) USP, Heat Treated.
What does Sanofi Aventis make?
Sanofi develops, manufactures, and distributes healthcare products and pharmaceuticals for diabetes solutions, human vaccines, rare diseases, emerging markets, and consumer healthcare.
Does Sanofi offer a pension?
At Sanofi, we empower you to save and build your future through a number of initiatives: Pension benefit and retirement contribution plans. Savings plans. A competitive employee share ownership plan – in addition to our generous compensation package – which enables you to invest in Sanofi shares at a discounted price.
What company owns Sanofi?
Sanofi
| Formerly | Sanofi-Synthélabo (1999–2004) Sanofi-Aventis (2004–2011) |
|---|---|
| Total equity | €59.10 billion (2019) |
| Number of employees | 99,412 (2020) |
| Subsidiaries | Sanofi Pasteur Genzyme Shantha Biotechnics Chattem Ablynx Bioverativ |
| Website | www.sanofi.com |
What are Sanofi Aventis tablets used for?
It is used to treat high blood pressure and heart failure. It may also be used as treatment following a heart attack (myocardial infarction) complicated with heart failure or to reduce the risk of heart attack or stroke.
What does Sanofi Pasteur do?
About Sanofi Pasteur Sanofi Pasteur, our vaccines global business unit, partners with the public health, medical and scientific communities to improve access to life-protecting vaccines and increase vaccination coverage, while striving to develop new and improved vaccines to enhance health and well-being.
